Cart
sales@molnova.com
WAY-309060
CAS No. 309951-18-6
WAY-309060( —— )
Catalog No. M28814 CAS No. 309951-18-6
WAY-309060 is a BRD4 small molecule inhibitor with antitumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 36 | Get Quote |
|
| 5MG | 58 | Get Quote |
|
| 10MG | 87 | Get Quote |
|
| 25MG | 178 | Get Quote |
|
| 50MG | 295 | Get Quote |
|
| 100MG | 484 | Get Quote |
|
| 200MG | 691 | Get Quote |
|
| 500MG | 1035 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameWAY-309060
-
NoteResearch use only, not for human use.
-
Brief DescriptionWAY-309060 is a BRD4 small molecule inhibitor with antitumor activity.
-
DescriptionWAY-309060 is a BRD4 small molecule inhibitor with antitumor activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number309951-18-6
-
Formula Weight262.26
-
Molecular FormulaC13H14N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (381.30 mM)
-
SMILESCc1cc(NC(c(cc2)cc(OC)c2OC)=O)no1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.LEXICON PHARMACEUTICALS INC - US2012/65200, 2012, A1
molnova catalog
related products
-
PBRM1-BD2-IN-5
PBRM1-BD2-IN-5 is a potent inhibitor of the PBRM1 Bromodomain, with dissociation constant (Kd) values of 1.5 μM and 3.9 μM for PBRM1-BD2 and PBRM1-BD5 respectively, and an inhibitory concentration 50 (IC50) value of 0.26 μM for PBRM1-BD2.
-
SGC-SMARCA-BRDVIII
SGC-SMARCA-BRDVIII is a potent and selective inhibitor of SMARCA2, SMARCA4, PB1(2), PB1(3) and PB1(5) with Kds of 35 nM, 36 nM, 3.7 μM, 2.0 μM and 13 nM, respectively.
-
BRD7-IN-1
BRD7-IN-1, a modified derivative of BI7273 (BRD7/9 inhibitor), forms PROTAC VZ185 via linkage to a VHL ligand, demonstrating potent activity against BRD7/9 with DC50 values of 4.5 and 1.8 nM, respectively .
